Equity Overview
Price & Market Data
Price: $0.266
Daily Change: -$0.0213 / 8.01%
Daily Range: $0.266 - $0.31
Market Cap: $33,033,621
Daily Volume: 2,014,457
Performance Metrics
1 Week: -18.24%
1 Month: -30.67%
3 Months: -59.24%
6 Months: -53.47%
1 Year: -57.30%
YTD: -54.56%
Company Details
Employees: 85
Sector: Health technology
Industry: Medical specialties
Country:
Details
VolitionRx Limited, a multi-national epigenetics company, develops blood tests to help detect and monitor a range of cancers, and diseases associated with NETosis in the United States, Europe, and Asia. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets, detects diseases associated with NETosis, such as sepsis; Nu.Q Discover, a solution to profiling nucleosomes; Nu.Q Cancer for predicting treatment response, monitoring treatment response and disease progression, and amending a patient's cancer treatment regimen; and Capture-PCR and Capture-Seq, which are isolating and capturing circulating tumor-derived DNA from plasma samples for early cancer detection. VolitionRx Limited is based in Henderson, Nevada.